Fosaprepitant-Induced Phlebitis: A Focus on Patients Receiving Doxorubicin/Cyclophosphamide Therapy

Supportive Care in Cancer- Germany

doi 10.1007/s00520-013-2089-8

Full Text

Abstract

Available in

Date

January 9, 2014

Authors

Publisher

Springer Science and Business Media LLC

Related search

An Analysis of Fosaprepitant-Induced Venous Toxicity in Patients Receiving Highly Emetogenic Chemotherapy

Supportive Care in Cancer

Oncology

2014

English

A Double‐blind, Randomized, Multicenter Phase 3 Study of Palonosetron vs Granisetron Combined With Dexamethasone and Fosaprepitant to Prevent Chemotherapy‐induced Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide

English

Effects of Ozone Therapy on Cyclophosphamide-Induced Urinary Bladder Toxicity in Rats

Clinical and Investigative Medicine

Medicine

2013

English

Pharmacogenetics of Toxicity of 5-Fluorouracil, Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients

Oncotarget

Oncology

2018

English

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Journal of Clinical Oncology

English

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health

2010

English

Alopecia in Dogs Submitted to a Combined Chemotherapy With Doxorubicin and Cyclophosphamide

Archives of Veterinary Science

Veterinary

2001

English

Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: A Hidden Menace

Hepatology International

Hepatology

2017

English

Assessing Treatment Motivation Among Patients Receiving Antiretroviral Therapy: A Multidimensional Approach

Psychology and Health

English

Amanote Research

Fosaprepitant-Induced Phlebitis: A Focus on Patients Receiving Doxorubicin/Cyclophosphamide Therapy

Supportive Care in Cancer- Germany

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

An Analysis of Fosaprepitant-Induced Venous Toxicity in Patients Receiving Highly Emetogenic Chemotherapy

A Double‐blind, Randomized, Multicenter Phase 3 Study of Palonosetron vs Granisetron Combined With Dexamethasone and Fosaprepitant to Prevent Chemotherapy‐induced Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide

Effects of Ozone Therapy on Cyclophosphamide-Induced Urinary Bladder Toxicity in Rats

Pharmacogenetics of Toxicity of 5-Fluorouracil, Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Alopecia in Dogs Submitted to a Combined Chemotherapy With Doxorubicin and Cyclophosphamide

Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: A Hidden Menace

Assessing Treatment Motivation Among Patients Receiving Antiretroviral Therapy: A Multidimensional Approach